Specialised Therapeutics partners with Treeway to license ALS drug

Specialised Therapeutics has entered into a licensing agreement with Treeway for TW001, designed for treating amyotrophic lateral sclerosis.

Aug 28, 2023 - 20:00

Specialised Therapeutics partners with Treeway to license ALS drug

Specialised Therapeutics has entered into a licensing agreement with Treeway for TW001, designed for treating amyotrophic lateral sclerosis.

Read the original article

Tags:

Previous Article

STAT+: Republican presidential candidates spar over abortion bans

Phebra, University of Wollongong partner to develop cancer therapies

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

OCX-063 by OccuRx for Proliferative Vitreoretinopathy (...

Jun 5, 2023

EMA approves Bavarian Nordic’s mpox vaccine for teenagers

EMA approves Bavarian Nordic’s mpox vaccine for teenagers

Sep 22, 2024

MSD closes $1.3bn EyeBio acquisition, plans pivotal trial for lead asset

MSD closes $1.3bn EyeBio acquisition, plans pivotal tri...

Jul 14, 2024